Lipe & Dalton’s Illumina ILMN Stock Holding History

Lipe & Dalton’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-257	Closed	-$51K	–	104
2022 Q4	$51K	Hold	257	–	–	0.03%	92
2022 Q3	$48K	Buy	+257	New	+$50.8K	0.03%	94

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lipe & Dalton's ILMN Position: Q1 2023 in Review

Lipe & Dalton sold out of Illumina (ILMN) in Q1 2023, closing a stake of 257 shares — an estimated $51K sold.

Lipe & Dalton first reported a position in ILMN in Q3 2022 and held it in 2 quarters. The position peaked at $51K in Q4 2022. 946 funds tracked by Wall St. Rank hold ILMN as of Q1 2023.

Lipe & Dalton reported no remaining Illumina position as of Q1 2023 after selling out during the quarter.
Lipe & Dalton sold 257 Illumina shares in Q1 2023, an estimated $51K.
Lipe & Dalton first reported a position in Illumina in Q3 2022 and held it in 2 quarters.
Lipe & Dalton's Illumina position peaked at $51K in Q4 2022.
946 funds tracked by Wall St. Rank held Illumina as of Q1 2023.

Based on Lipe & Dalton's 13F filing for Q1 2023, filed 2 May 2023.